Matches in SemOpenAlex for { <https://semopenalex.org/work/W2353282014> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2353282014 endingPage "3" @default.
- W2353282014 startingPage "1350" @default.
- W2353282014 abstract "Atofloding (ATFU) is a new derivative of 5-fluorouracil. The phase I and II clinical study have been finished. The current study was a phase III clinical trail of ATFU. The aim of this study was to evaluate the efficacy, toxicity of ATFU combination chemotherapy and compare with ftorafur (FT-207) in patients with gastric cancer, colorectal, esophageal cancer, and liver cancer.A multicenter, open randomized controlled trial was carried out. A total of 320 patients with gastric cancer, colorectal, esophageal cancer and liver cancer were randomized into ATFU group (study group) and FT207 group (control group) (a ratio of 2:1), treated with MMC + VP-16 + ATFU (FT-207), DDP + HCPT + ATFU (FT-207), DDP + VDS + ATFU (FT-207), and ADM + MMC + ATFU (FT-207) regimen, respectively. The same dosage of combine drugs were used in the two groups.The response rates of the study group (213 cases) and the control group (107 cases) were 17.1% and 7.9% in gastric cancer (P > 0.05), 16.7% and 9.4% in colorectal cancer (P > 0.05), 20.0% and 24.6% in esophageal cancer (P > 0.05), 5.0% and 9.0% in liver cancer (P > 0.05), respectively. The major adverse effects were mylosuppression and gastrointestinal reactions which frequency and intensity had no statistical difference in the two groups.ATFU combination chemotherapy is effective and similar to FT207 in the efficiency and adverse effects for treatment of advanced GI cancers." @default.
- W2353282014 created "2016-06-24" @default.
- W2353282014 creator A5000867864 @default.
- W2353282014 creator A5000984425 @default.
- W2353282014 creator A5001923780 @default.
- W2353282014 creator A5022240408 @default.
- W2353282014 creator A5022802322 @default.
- W2353282014 creator A5024496255 @default.
- W2353282014 creator A5027475930 @default.
- W2353282014 creator A5029000628 @default.
- W2353282014 creator A5048959292 @default.
- W2353282014 creator A5085830272 @default.
- W2353282014 creator A5086195385 @default.
- W2353282014 date "2002-12-01" @default.
- W2353282014 modified "2023-09-27" @default.
- W2353282014 title "[Phase III clinical study of a new anticancer drug atofluding]." @default.
- W2353282014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12520746" @default.
- W2353282014 hasPublicationYear "2002" @default.
- W2353282014 type Work @default.
- W2353282014 sameAs 2353282014 @default.
- W2353282014 citedByCount "5" @default.
- W2353282014 countsByYear W23532820142017 @default.
- W2353282014 crossrefType "journal-article" @default.
- W2353282014 hasAuthorship W2353282014A5000867864 @default.
- W2353282014 hasAuthorship W2353282014A5000984425 @default.
- W2353282014 hasAuthorship W2353282014A5001923780 @default.
- W2353282014 hasAuthorship W2353282014A5022240408 @default.
- W2353282014 hasAuthorship W2353282014A5022802322 @default.
- W2353282014 hasAuthorship W2353282014A5024496255 @default.
- W2353282014 hasAuthorship W2353282014A5027475930 @default.
- W2353282014 hasAuthorship W2353282014A5029000628 @default.
- W2353282014 hasAuthorship W2353282014A5048959292 @default.
- W2353282014 hasAuthorship W2353282014A5085830272 @default.
- W2353282014 hasAuthorship W2353282014A5086195385 @default.
- W2353282014 hasConcept C121608353 @default.
- W2353282014 hasConcept C126322002 @default.
- W2353282014 hasConcept C143998085 @default.
- W2353282014 hasConcept C168563851 @default.
- W2353282014 hasConcept C197934379 @default.
- W2353282014 hasConcept C2776231280 @default.
- W2353282014 hasConcept C2776694085 @default.
- W2353282014 hasConcept C2777299880 @default.
- W2353282014 hasConcept C2779742542 @default.
- W2353282014 hasConcept C2780456651 @default.
- W2353282014 hasConcept C2781413609 @default.
- W2353282014 hasConcept C3019864225 @default.
- W2353282014 hasConcept C31760486 @default.
- W2353282014 hasConcept C526805850 @default.
- W2353282014 hasConcept C535046627 @default.
- W2353282014 hasConcept C71924100 @default.
- W2353282014 hasConcept C90924648 @default.
- W2353282014 hasConceptScore W2353282014C121608353 @default.
- W2353282014 hasConceptScore W2353282014C126322002 @default.
- W2353282014 hasConceptScore W2353282014C143998085 @default.
- W2353282014 hasConceptScore W2353282014C168563851 @default.
- W2353282014 hasConceptScore W2353282014C197934379 @default.
- W2353282014 hasConceptScore W2353282014C2776231280 @default.
- W2353282014 hasConceptScore W2353282014C2776694085 @default.
- W2353282014 hasConceptScore W2353282014C2777299880 @default.
- W2353282014 hasConceptScore W2353282014C2779742542 @default.
- W2353282014 hasConceptScore W2353282014C2780456651 @default.
- W2353282014 hasConceptScore W2353282014C2781413609 @default.
- W2353282014 hasConceptScore W2353282014C3019864225 @default.
- W2353282014 hasConceptScore W2353282014C31760486 @default.
- W2353282014 hasConceptScore W2353282014C526805850 @default.
- W2353282014 hasConceptScore W2353282014C535046627 @default.
- W2353282014 hasConceptScore W2353282014C71924100 @default.
- W2353282014 hasConceptScore W2353282014C90924648 @default.
- W2353282014 hasIssue "12" @default.
- W2353282014 hasLocation W23532820141 @default.
- W2353282014 hasOpenAccess W2353282014 @default.
- W2353282014 hasPrimaryLocation W23532820141 @default.
- W2353282014 hasRelatedWork W114118577 @default.
- W2353282014 hasRelatedWork W1984322631 @default.
- W2353282014 hasRelatedWork W2240675528 @default.
- W2353282014 hasRelatedWork W2285760215 @default.
- W2353282014 hasRelatedWork W2321029249 @default.
- W2353282014 hasRelatedWork W2353282014 @default.
- W2353282014 hasRelatedWork W2382089826 @default.
- W2353282014 hasRelatedWork W2411966616 @default.
- W2353282014 hasRelatedWork W2412701647 @default.
- W2353282014 hasRelatedWork W2972697340 @default.
- W2353282014 hasVolume "21" @default.
- W2353282014 isParatext "false" @default.
- W2353282014 isRetracted "false" @default.
- W2353282014 magId "2353282014" @default.
- W2353282014 workType "article" @default.